Moxifloxacin (1.5g), Lysozyme (200mg), Lactic Acid Bacillus (220 Million Spores), Levocetirizine (25mg), and Magnesium Trisilicate (50mg). Veterinary Bolus

Formulated specifically for cattle, sheep, and goats, this potent veterinary bolus combines Moxifloxacin (1.5g), Lysozyme (200mg), Lactic Acid Bacillus (220 Million Spores), Levocetirizine (25mg), and Magnesium Trisilicate (50mg). It provides powerful defense against bacterial infections, supports gut health, and eases allergy-related inflammation, ensuring rapid recovery and optimal livestock health.

Moxifloxacin 1.5 g + Lysozyme 200 mg + Lactic Acid Bacillus 220 Million Spores + Levocetirizine 25 mg + Magnesium Trisilicate 50 mg Veterinary Bolus is a multi-ingredient veterinary formulation combining an antibacterial agent, an enzyme, a probiotic, an antihistamine and an antacid to provide different pharmacological actions. Moxifloxacin belongs to the fluoroquinolone group of antibiotics and works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for bacterial DNA replication, repair and multiplication. This action helps control susceptible bacterial infections when the organism is sensitive to the antibiotic. Lysozyme is an enzyme with antibacterial properties that acts by breaking down components of bacterial cell walls, particularly in susceptible organisms, and may provide complementary antimicrobial support. Lactic Acid Bacillus is a probiotic microorganism that helps maintain a healthy intestinal microbial balance by supporting beneficial gut flora and intestinal function. It may assist in maintaining digestive health and supporting recovery of normal gut microflora, particularly when intestinal microbial balance is disturbed. Levocetirizine is a second-generation antihistamine that selectively blocks H1 histamine receptors, helping reduce histamine-related allergic symptoms such as itching, irritation and hypersensitivity reactions. Magnesium trisilicate acts as an antacid by neutralising excess gastric acid and may help provide relief from acidity-related gastric discomfort. Together, these ingredients are intended to provide a combination of antibacterial, probiotic, antihistaminic and gastric-supportive actions, depending on the approved formulation and target animal species. The bolus dosage form is designed for oral administration and may offer convenient dosing in livestock when prescribed by a veterinarian. Possible adverse effects may include digestive disturbances, reduced appetite, allergic reactions or changes in intestinal activity. Fluoroquinolone antibiotics require careful veterinary supervision because inappropriate use can contribute to antimicrobial resistance and may be restricted in food-producing animals. The stated strengths, particularly Moxifloxacin 1.5 g and Levocetirizine 25 mg, are unusual and must be carefully verified against the approved formulation, target animal species and product label before marketing or administration. The suitability of combining all five ingredients should also be confirmed by a qualified veterinary formulator. Use only under veterinary guidance, follow the prescribed dosage and observe all applicable meat and milk withdrawal requirements.